Attached files
file | filename |
---|---|
EX-10.1 - CONTRACT - ALTAIR NANOTECHNOLOGIES INC | altair_8k-ex1001.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (date of earliest event reported): September 3,
2009
Altair Nanotechnologies Inc.
(Exact
Name of Registrant as Specified in its Charter)
Canada | 1-12497 | 33-1084375 | ||
(State or other
jurisdiction of
incorporation or
organization)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
204
Edison Way
Reno, NV
|
89502 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant's
Telephone Number, Including Area Code:
(801) 858-3750
N/A
(Former
name, former address, and formal fiscal year, if changed since last
report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
o Written communications pursuant
to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)
TABLE OF
CONTENTS
Item
1.01
|
Entry
into Material Definitive Agreement
|
Item
9.01
|
Exhibits
|
SIGNATURES
EXHIBIT
INDEX
EX.
10.1:
|
Contract
dated September 3, 2009 with the U.S. Army RDECOM Acquisition
Center.
|
2
Item
1.01
|
Entry
into Material Definitive Agreement
|
On
September 3, 2009, Altair Nanotechnologies Inc. (the "Company") through is
wholly owned subsidiary Altairnano, Inc. signed a cost reimbursement contract
with the U.S. Army RDECOM Acquisition Center (“U.S. Army”) for up to
$1,749,965.00 (the “Contract”). The Contract calls for
Altairnano, Inc. to conduct primary research of sensitive and selective
nanosensors through a single molecule-multiple excitation source approach to
synthesize a single sensing molecule coupled with metal nanoparticles to better
understand how the molecule responds to nerve and toxic industrial chemicals and
to incorporate the technology into a portable sensing device. The term of the
Contract runs through September 2, 2010.
The
description of the Contract set forth above is, by its nature, a summary
description and omits certain detailed terms set forth in the underlying
agreement. The summary set forth above is qualified by the terms and
conditions of the Contract attached as Exhibit 10.1 to this Current
Report.
Item
9.01
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits.
|
|
10.1
|
Contract
dated September 3, 2009 with the U.S. Army RDECOM Acquisition
Center.
|
3
SIGNATURES
Pursuant to the requirements of the
Securities Exchange of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
Altair Nanotechnologies Inc. | |||
Dated: October
12, 2009
|
By:
|
/s/ John Fallini | |
John Fallini, Chief Financial Officer | |||
4